ISSN 0350-8218 (Print)
ISSN 2303-7954 (Online)

Volume 47, Issue 1, Article 8

(Scr Med 2016:47:47-52)

ORIGINAL ARTICLE

Outpatient antibiotic consumption in the Republic of Srpska during the period from 2009 to 2014

Ljubica Bojanić 1, Mirjana Đermanović 1,2,  Janja Bojanić 1,2, Jela Aćimović 1, Vanda Marković-Peković 2,3

1 Public Health Institute, Republic of Srpska
2 Faculty of Medicine, University in Banja Luka
3 Ministry of Health and Social Welfare of the Republic of Srpska

doi:10.18575/msrs.sm.e.16.08
UDC: 615.33(497.6 Republika Srpska) “2009/2014”
COBISS.RS-ID: 5703704

ABSTRACT
Introduction. Antimicrobial resistance is a very serious public health threat worldwide. The main cause of antimicrobial resistance is irrational use of antimicrobial drugs. The goal of the article is to analyze data on outpatient antibiotic consumption in the Republic of Srpska during the period from 2009 to 2014, to present outpatient consumption of the fi rst six antibiotics (the fi fth level of the ATC classifi cation), and, finally, to compare the antibiotic use in Republic of Srpska in relation to the antibiotic use in European Union countries.

Materials and Methods. Collection and analysis of data on drug consumption is done using ATC/DDD methodology, established by the WHO. Data are taken from the report on drug consumption and distribution in the Republic of Srpska during the period from 2009 to 2014, which are based on submitted data from pharmacies registered in the Republic of Srpska.

Results. Results on outpatient antibiotic consumption in the Republic of Srpska, during the period from 2009 to 2014, indicate a total decrease by 3.41 DDDs/1000 inhabitants/day, with the exception of 2010 and 2013, when the antibiotic consumption was increased. In 2014, total outpatient antibiotic consumption in the Republic of Srpska was 31.2% lower than the average consumption in the European Union. During the period from 2010 to 2014, the European Union had a significant increase in antibiotic consumption, while antibiotic consumption in the Republic of Srpska had a tendency of falling.

Conclusion. Presented results show a quantitative analysis of antibiotic consumption and provide insight into the outpatient use of antibiotics in the Republic of Srpska, and can be used for further pharmacoepidemiological analysis of antibiotic consumption, which would give a better insight into the therapeutic practice, with the aim of improving the rational pharmacotherapy in the Republic of Srpska.

Keywords: antibiotics, outpatient consumption, DDD/1000 inhabitants/day

PDF version of article

References
1. Rustam I. Aminov. A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in microbiology. Review Article published: 08 December 2010. http://dx.doi.org/10.3389/fmicb.2010.00134
2. Roca I, Akova M, Baquero F, CarletJ, Cavaleri M, Coenen S, et al. Global threat of antimicrobial resistance: science for intervention. New Microbe and New Infect 2015; 6: 22–29. http://dx.doi.org/10.1016/j.nmni.2015.02.007  PMid:26029375 PMCid:PMC4446399
3. European Commission. Progress report on the action plan against the rising threats from antimicrobial resistance. 2015.
http://ec.europa.eu/health/antimicrobial_resistance/docs/2015_amr_progress_report_en.pdf
4. WHO. Antimicrobial resistance factsheet. 2015. http://www.who.int/mediacentre/factsheets/fs194/en/
5. ECDC, EMEA.Technical report. The bacterial challenge: time to react. 2009. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2009/11/WC500008770.pdf
6. Fitchett J.R, Atun R. Antimicrobial resistance: opportunity for Europe to establish global leadership. Lancet infect Dis 2015. Published Online December 18, 2015. http://dx.doi.org/10.1016/S1473-3099(15)00410-7
7. Taylor J, Hafner M, Yerushalmi E, Smith R, Bellasio J, Vardavas R, et al. Estimating the economic costs of antimicrobial resistance: model and results. 2014. http://www.rand.org/content/dam/rand/pubs/research_reports/RR900/RR911/RAND_RR911.pdf 
8. WHO Policy Perspectives on Medicines – Promoting rational use of medicines : core components. Sep 2002. Geneva
9. World Health Organization. Guidelines for ATC classifi cation and DDD assignment. http://www.whocc.no/atc_ddd_publications/guidelines
10. World Health Organization. ATC Index with DDDs. http://www.whocc.no/atc_ddd_index
11. Zakon o apotekarskoj djelatnosti (Sl. glasnik Republike Srpske, br. 119/08).
12. Zakon o evidencijama i statističkim istraživanjima u oblasti zdravstvene zaštite (Sl. glasnik Republike Srpske, br. 53/07)
13. Pravilnik o sadržaju i načinu vođenja izvještaja o prometu i potrošnji lijekova (Sl. glasnik Republike Srpske, br. 65/11)).
 14. Institut za javno zdravstvo, Republika Srpska. Izvještaj o potrošnji i prometu gotovih lijekova u Republici Srpskoj. 2009, 2010, 2011, 2012, 2013, 2014. godina
15. European Centre for Disease Prevention and Control. Key messages for primary care prescribers. 2015-2016. http://ecdc.europa.eu/en/eaad/antibiotics-get-informed/key-messages/Pages/primary-care-prescribers.aspx 
16. Gossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group.Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365(9459):579-87. http://dx.doi.org/10.1016/S0140-6736(05)70799-6 
17. European Center for Desease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data. November 2015.

Corresponding author:
Ljubica Bojanić
Nikole Bokana 10
78000 Banja Luka, BiH;
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Telephone: + 387 65 694 489

Submitted: January 28th, 2016
Accepted: Februar 8th, 2016